Literature DB >> 6488482

Vasopressin causes endothelium-dependent relaxations of the canine basilar artery.

Z S Katusic, J T Shepherd, P M Vanhoutte.   

Abstract

The effect of synthetic 8-arginine vasopressin (vasopressin) was studied in isolated canine basilar, left circumflex coronary, and femoral arteries of the dog. Vascular rings with and without endothelium were suspended for isometric tension recording in physiological salt solution. The removal of the endothelium was confirmed by the absence of relaxations induced by either thrombin (basilar arteries) or acetylcholine (coronary and femoral arteries). In the basilar artery, vasopressin induced concentration-dependent inhibition of myogenic tone. In basilar and coronary arteries, the hormone caused concentration-dependent relaxations during contractions evoked by prostaglandin F2 alpha. In femoral arteries, vasopressin caused contraction. After removal of the endothelium, the inhibitory responses to vasopressin were abolished in basilar arteries and significantly reduced in left circumflex coronary arteries. The contractions of femoral arteries were not affected by endothelium removal. The V1-vasopressinergic antagonist d(CH2)5Tyr(Me)AVP prevented the inhibitory response to vasopressin, but did not alter endothelium-dependent relaxations of basilar arteries caused by adenosine diphosphate. These results demonstrate that the endothelial cells mediate relaxation induced by vasopressin via specific V1-vasopressinergic receptors.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6488482     DOI: 10.1161/01.res.55.5.575

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  33 in total

1.  Cerebral vasoconstriction produced by vasopressin in conscious goats: role of vasopressin V(1) and V(2) receptors and nitric oxide.

Authors:  N Fernández; M A Martínez; A L García-Villalón; L Monge; G Diéguez
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

2.  An immunohistochemical study of endothelial cell heterogeneity in the rat: observations in "en face" Häutchen preparations.

Authors:  A Tomlinson; H Van Vlijmen; A Loesch; G Burnstock
Journal:  Cell Tissue Res       Date:  1991-01       Impact factor: 5.249

3.  Localization of arginine-vasopressin in endothelial cells of rat pulmonary artery.

Authors:  A Loesch; A Tomlinson; G Burnstock
Journal:  Anat Embryol (Berl)       Date:  1991

4.  Mechanisms underlying beta2-adrenoceptor-mediated nitric oxide generation by human umbilical vein endothelial cells.

Authors:  Lindsay R Queen; Yong Ji; Biao Xu; Lora Young; Kang Yao; Amanda W Wyatt; David J Rowlands; Richard C M Siow; Giovanni E Mann; Albert Ferro
Journal:  J Physiol       Date:  2006-07-27       Impact factor: 5.182

Review 5.  Role of nitric oxide in progression and regression of atherosclerosis.

Authors:  J P Cooke
Journal:  West J Med       Date:  1996-05

6.  Cyclic GMP stimulation by vasopressin in LLC-PK1 kidney epithelial cells is L-arginine-dependent.

Authors:  H Schröder; K Schrör
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-10       Impact factor: 3.000

7.  Use of vasopressin in neonatal hypertrophic obstructive cardiomyopathy: case series.

Authors:  Stephanie M Boyd; Kristin L Riley; Regan E Giesinger; Patrick J McNamara
Journal:  J Perinatol       Date:  2020-09-19       Impact factor: 2.521

8.  Regional differences in the arterial response to vasopressin: role of endothelial nitric oxide.

Authors:  A L García-Villalón; J L Garcia; N Fernández; L Monge; B Gómez; G Diéguez
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

9.  Nitric oxide-dependent beta2-adrenergic dilatation of rat aorta is mediated through activation of both protein kinase A and Akt.

Authors:  Albert Ferro; Marcy Coash; Takahiro Yamamoto; Jubli Rob; Yong Ji; Lindsay Queen
Journal:  Br J Pharmacol       Date:  2004-09-06       Impact factor: 8.739

10.  Contractile effects of perivascularly applied vasopressin on the pial artery of the cat brain.

Authors:  M Nakai
Journal:  J Physiol       Date:  1987-06       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.